1 enrolling by invitation. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
Albuminuria (1) · Diabetes Mellitus, Type 2 (1) · Renal Insufficiency, Chronic (1)
Chronic Disease (1) · Diabetes Mellitus (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Proteinuria (1) · Renal Insufficiency (1)
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1) · Canagliflozin (1) · Captopril (1) · Enalapril (1) · Fosinopril (1) · Irbesartan (1) · Lisinopril (1) · Losartan (1) · Olmesartan Medoxomil (1) · Perindopril (1) · Quinapril (1) · Ramipril (1) · Telmisartan (1) · Valsartan (1) · azilsartan (1)
United States (1)